Craig H. Mallinckrodt, PhD: Simple Options for Improving Signal Detection in Antidepressant Clinical Trials

Name: Craig H. Mallinckrodt, PhD: Simple Options for Improving Signal Detection in Antidepressant Clinical Trials
SKU: 2769
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 40 No. 2 Articles Tags: adam-l-meyers, antidepressants, apurva-prakash, ba, clinical-trials, craig-h-mallinckrodt, douglas-e-faries, major-depressive-disorder, md, medworks-media, methodology, michael-j-detke, ms, phd, psychopharmacology-bulletin, signal-detection

Description

Craig H. Mallinckrodt, PhD: Simple Options for Improving Signal Detection in Antidepressant Clinical Trials

Description

Craig H. Mallinckrodt, PhD

EVIDENCE-BASED MEDICINE

Simple Options for Improving Signal Detection in Antidepressant Clinical Trials

Craig H. Mallinckrodt, PhD, Adam L. Meyers, MS, Apurva Prakash, BA, Douglas E. Faries, PhD, and Michael J. Detke, MD, PhD

Antipsychotics Case Study by Yuan-Hwa Chou

Test of Treatment in Psychiatric Practice by Feras Ali Mustafa

Paroxysmal Perceptual Alteration Case Study by Samir Kumar Praharaj

Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3

Craig H. Mallinckrodt, PhD: Simple Options for Improving Signal Detection in Antidepressant Clinical Trials

Description

Craig H. Mallinckrodt, PhD

EVIDENCE-BASED MEDICINE

Simple Options for Improving Signal Detection in Antidepressant Clinical Trials

Craig H. Mallinckrodt, PhD, Adam L. Meyers, MS, Apurva Prakash, BA, Douglas E. Faries, PhD, and Michael J. Detke, MD, PhD

Related products

Antipsychotics Case Study by Yuan-Hwa Chou

Test of Treatment in Psychiatric Practice by Feras Ali Mustafa

Paroxysmal Perceptual Alteration Case Study by Samir Kumar Praharaj

Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3